Today is about the slow stuff finally moving faster. Regulators are weighing a blood-pressure drug that goes after the hormone behind stubborn hypertension, the first genuinely new stop-smoking pill in two decades, and a COVID pill you take after exposure instead of after symptoms. We read the filings so you can skip them.
Read today’s brief →
The diagnostic shift is real. Here’s how to put a piece of it in your own home.
Read the full issue →
Function Health and the at-home testing boom — what full-panel blood work actually tells you.
6,000 studies, wild claims. Where the evidence is real — and the panels worth buying.
AirPods Pro 3 are FDA-registered hearing aids now — the $249 option vs the $2,000 one.
The 2026 research says it helps the aging brain, not just muscle. Here’s what’s worth taking.
Over-the-counter glucose monitors are here for everyone. What the data tells you — and what to buy.
20.7% weight loss, no needles — and the 4 products GLP-1 users actually need.
“Finally a health publication that respects my time. The story, the science, what to buy. Done.”
“The evidence grades are the killer feature. I know in one glance whether to trust a claim.”
“I forward VITALS to my whole clinic. The only brief that’s fast AND sourced.”
Yes. The brief is free, every morning. We earn through clearly-disclosed affiliate links and sponsorships — never by charging you.
No. VITALS reports on medicine and health products; it is not medical advice. Always talk to a qualified clinician about your own health.
Every claim gets a VITALS Score — Replicated, Promising, Preliminary, Weak or Debunked — so you can tell strong science from a single-study headline at a glance.
When we recommend a product, the link is often an affiliate link — we may earn a commission at no cost to you. We grade the evidence before any product is linked, and a commission never changes a grade.
Join the VITALS list. 3 mornings a week, free — the one health story worth your morning, and what (if anything) is worth buying.